Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.31 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18803284 | 0.71 | NLRP3 (0.35) | KMT2AMEN1ALDH1A1SMN1; SMN2GAA | |
| SCHEMBL2523214 | 0.63 | KDM4E (0.49) | KMT2AMEN1ALDH1A1SMN1; SMN2GAA | |
| SCHEMBL1417236 | 0.62 | POLB (0.48) | KMT2AMEN1ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL29512022 | 0.62 | POLB (0.48) | KMT2AMEN1ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL2237455 | 0.61 | — | — | |
| SCHEMBL22984920 | 0.61 | TSHR (0.44) | KMT2AMEN1ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL5121422 | 0.60 | ALDH1A1 (0.61) | KMT2AMEN1ALDH1A1POLBGAA | |
| SCHEMBL29035804 | 0.60 | KMT2A (0.36) | KMT2AMEN1ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL19264696 | 0.60 | SLC6A3 (0.40) | NLRP3 | |
| Hydrochloric Acid SCHEMBL29771988 | 0.60 | POLB (0.47) | KMT2AMEN1ALDH1A1POLBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3164196-B1 | TOPICAL FORMULATIONS FOR UV PROTECTION | TOPGENIX INC (US) | 2021-08-18 | — | — | EP | disclosed |
| US-20170119641-A1 | TOPICAL FORMULATIONS FOR UV PROTECTION | TopGeniX, Inc. | 2017-05-04 | — | — | US | disclosed |
| US-20170119641-A1 | TOPICAL FORMULATIONS FOR UV PROTECTION | TopGeniX, Inc. | 2017-05-04 | — | — | US | disclosed |
| WO-2015195546-A1 | TOPICAL FORMULATIONS FOR UV PROTECTION | TopGeniX, Inc. (US) | 2015-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170119641-A1 | TOPICAL FORMULATIONS FOR UV PROTECTION | ERCC4, ERCC1, UNG | KMT2A 4590/4885MEN1 3883/4885ALDH1A1 417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.